- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£207.1b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£133.54
7D
-8.1%
1Y
25.7%
Gilead Sciences
Market Cap: US$168.6b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$134.84
7D
2.7%
1Y
17.7%
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,389.00
7D
-3.3%
1Y
8.1%
Orion Oyj
Market Cap: €9.9b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€70.55
7D
-2.2%
1Y
5.5%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥55.3b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥122.94
7D
-6.1%
1Y
29.7%
Xiamen Amoytop Biotech
Market Cap: CN¥22.7b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥55.70
7D
-4.8%
1Y
-26.5%
PharmaResearch
Market Cap: ₩3.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩319,500.00
7D
-6.3%
1Y
-43.0%